Genetic Signatures Ltd (ASX: GSS) Share Price and News

Mr Anthony Radford was a member of the CSIRO team that invented the QuantiFERON method for Cellular Immune based diagnostics. He later joined Amrad in pharmaceutical research and was Head of Development in 2000. Establishing offices and operations in the USA, Europe and Japan, Cellestis developed QuantiFERON TB Gold, the worldwide benchmark for diagnosis of tuberculosis infection. Dr. Radford was CEO of Cellestis from founding until its acquisition by QIAGEN NV in 2011.He is a Fellow of the Australian Academy of Technology and Engineering, and a recipient of their Clunies Ross Prize.He is member of Risk Committee.

Ms Waldron is a cross-border advisor and director with over 30 years in governance,marketing,human resources and digital transformation across a range of sectors.Her formal training is in law and she has been admitted to the Bar of England and Wales and the courts of other jurisdictions including Australia and New Zealand. She is Chair of Risk Committee.

Mr Samaras has had over 30 years' business experience in the global Life Sciences industry and is a industry expert. He has held a number of senior executive level positions in management, marketing, sales, and research and development. His roles have included appointments as Managing Director of Applied Biosystems Pty Ltd (now part of Thermo Fisher), and senior roles with Perkin Elmer and AMRAD Corporation now part of CSL. Dr. Samaras is an experienced executive, non-executive and Board Chairman, having served on the boards of several biotechnology companies.

Mr Aicher has over 30 years of industry experience and was CEO and founder of National Genetics Institute NGI which was acquired by Laboratory Corporation of America,Inc.LabCorp in 2000.Mr Aicher led LabCorp's Esoteric Business Units, which generated more than $1 billion in annual revenue. Prior to NGI, Mr. Aicher served in a number of executive leadership roles at Central Diagnostics Laboratory. He currently serves as a director on boards of Roswell Biotechnologies,Techcyte and CytoBay.He is certified by the University of California at Berkeley as a Global Biotechnology Executive and is a recipient of Ernst & Young's 'Entrepreneur of the Year' award for emerging technologies.Mr Aicher received a BS in Business Administration from the University of Redlands.

Mr Melki has led the commercialisation efforts of Genetic Signatures as Chief Executive Officer since 2011. Dr. Melki originally joined Genetic Signatures in 2003 where he was responsible for leading the commercialisation of two research products worldwide and five diagnostic products locally and Europe in the role of Senior Principal Research Scientist. He has authored over 20 peer-reviewed articles and is listed as an inventor on eight patent applications. His primary research focus was in the sodium bisulphite conversion of DNA which is at the core of Genetic Signatures'3base technology.

Mr Gunn has over 30 years' experience in medical devices and diagnostics. Most recently Dr Gunn was CEO of ID byDNA, a metagenomics company based in the US that was acquired by Illumina in 2022. Prior to this he was the President of Roche Sequencing Solutions where he oversaw all aspects of the business and managed a team of approximately 900 people. His team developed and launched more than 20 products per year. Dr Gunn was also previously Vice President of Roche's Molecular Diagnostics business and was responsible for over 120 diagnostic product launches principally into the IVD clinical market. Dr Gunn is based in San Francisco, USA.

Mr Chatonsky has over 25 years of international experience including leadership roles in venture capital, private equity, investment banking, strategy and strategic advisory services.
Mr Chatonsky has held senior executive roles with global organisations such as Lazard, McKinsey & Co, Macquarie Bank and LeapFrog Investments. In addition, he has held Non-Executive Director, Chair and advisory positions for several leading pathology, healthcare and technology companies.

-

-